Literature DB >> 12809930

Muscle-derived stem cells seeded into acellular scaffolds develop calcium-dependent contractile activity that is modulated by nicotinic receptors.

Shing-Hwa Lu1, Tracy W Cannon, Christopher Chermanski, Ryan Pruchnic, George Somogyi, Michael Sacks, William C de Groat, Johnny Huard, Michael B Chancellor.   

Abstract

OBJECTIVES: To explore the contractile activity and physiologic properties of muscle-derived stem cells (MDSCs) incorporated into small intestinal submucosa (SIS) scaffolds.
METHODS: MDSCs were harvested from mice hind leg muscles using the preplate technique and stably transfected with a plasmid to express the LacZ reporter gene. Fifty different preparations of SIS cultured with MDSCs (MDSC/SIS) or SIS alone were incubated at 37 degrees C for 1, 4, and 8 weeks and also were mounted in a bath to measure the isometric contractions.
RESULTS: LacZ and Masson-trichrome staining revealed MDSCs could migrate into and distribute throughout the SIS and form myotubes. In MDSC/SIS, spontaneous contractile activities were noted in the 4-week (five of six specimens) and 8-week (eight of eight specimens) cultures, but not in 1-week cultures (n = 11). All SIS control groups after 1 (n = 11), 4 (n = 6), and 8 (n = 8) weeks of incubation did not show any activity. In most of the 4-week, and all of the 8-week, MDSC/SIS cultures, the frequency and amplitude of spontaneous contractile activities were decreased by succinylcholine 10 microM and 20 microM. Electrical field stimulation, carbachol, and KCl did not alter the frequency, amplitude, or pattern of spontaneous contractile activities in MDSC/SIS. Spontaneous contractile activities were blocked by Ca(32+)-free Krebs solution with ethyleneglycoltetraacetic acid 200 microM and distilled water.
CONCLUSIONS: MDSCs could be incorporated into SIS-forming myotubes capable of contracting. The contractile activity of this three-dimensional construct is Ca(2+) dependent and is modulated by nicotinic receptors. MDSC seeding of an acellular matrix may become a functional sling to reengineer the deficient sphincter or as contractile bladder augmentation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809930     DOI: 10.1016/s0090-4295(03)00020-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Advances toward tissue engineering for the treatment of stress urinary incontinence.

Authors:  Ron Jankowski; Ryan Pruchnic; Michael Hiles; Michael B Chancellor
Journal:  Rev Urol       Date:  2004

Review 2.  The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering.

Authors:  George Christ; Karl-Erik Andersson; Anthony Atala
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

3.  Advances in stem cell therapy for the lower urinary tract.

Authors:  Ching-Shwun Lin
Journal:  World J Stem Cells       Date:  2010-02-26       Impact factor: 5.326

4.  Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction.

Authors:  Mathias Tremp; Souzan Salemi; Remo Largo; Karl-Erik Andersson; Jan A Plock; Jan Plock; Tamer Aboushwareb; Tullio Sulser; Daniel Eberli
Journal:  World J Urol       Date:  2013-11-12       Impact factor: 4.226

5.  Characterization of smooth muscle differentiation of purified human skeletal muscle-derived cells.

Authors:  Shing-Hwa Lu; Alex T L Lin; Kuang-Kuo Chen; Han Sun Chiang; Luke S Chang
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

Review 6.  The Current Use of Stem Cells in Bladder Tissue Regeneration and Bioengineering.

Authors:  Yvonne Y Chan; Samantha K Sandlin; Eric A Kurzrock; Stephanie L Osborn
Journal:  Biomedicines       Date:  2017-01-06

Review 7.  Gene therapy treatments for erectile and bladder dysfunction.

Authors:  George J Christ
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

Review 8.  Treatment of bladder dysfunction using stem cell or tissue engineering technique.

Authors:  Jae Heon Kim; Hong Jun Lee; Yun Seob Song
Journal:  Korean J Urol       Date:  2014-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.